MEGF10 and myopathy: Similarly to Notch, deficits seen with MEGF10 myopathy have suggested MEGF10 as a target for potential therapies for muscle diseases; rescuing MEGF10 may have therapeutic implications with regard to ameliorating impaired muscle regeneration (Li et al., 2021).